Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Advisory Committee speaks on licensure of pneumococcal conjugate vaccines

Nov. 23, 2005

DOR plans U.S. and E.U. submissions for orBec

Nov. 22, 2005

FDA meets to consider pneumococcal conjugate vaccine approvals

Nov. 21, 2005

Novel oligonucleotides for immunological disorders emerge from Coley R&D

Nov. 9, 2005

Roche and Protein Design Labs expand daclizumab agreement

Nov. 4, 2005

Eisai licenses E-6020 vaccine adjuvant to Sanofi Pasteur

Nov. 3, 2005

Immunomodulatory agents described in Novartis patents

Oct. 28, 2005

Belatacept reported effective in renal transplant recipients at higher risk of CAN

Oct. 27, 2005

Brx-019 boosts immune response in diabetic mice

Oct. 25, 2005

Hydroxytyrosol protects the kidney against ciclosporin-evoked oxidative stress

Oct. 25, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...